Features of pathogenetic mechanisms of protein-energy wasting development in patients with chronic kidney disease stage 5D
- 作者: Kuzyarova A.S1, Gasanov M.Z2, Batyushin M.M2, Bogomolova K.R2, Adamokova I.H2
-
隶属关系:
- ООО Dialysis Center Nephros-Don
- Rostov State Medical University
- 期: 卷 12, 编号 4 (2020)
- 页面: 60-64
- 栏目: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/273349
- DOI: https://doi.org/10.18565/nephrology.2020.4.60-64
- ID: 273349
如何引用文章
详细
全文:
作者简介
A. Kuzyarova
ООО Dialysis Center Nephros-Don
Email: lina.kuzyarova@mail.ru
Cand. Sci. (Med.), Nephrologist Rostov-on-Don, Russia
M. Gasanov
Rostov State Medical University
Email: mitkhat@mail.ru
Cand. Sci. (Med.), Associate Professor at the Department of Internal Diseases № 1 Rostov-on-Don, Russia
M. Batyushin
Rostov State Medical University
Email: batjushin-m@rambler.ru
Dr. Sci. (Med.), Professor at the Department of Internal Diseases №. 2, Head of the Nephrology Department Rostov-on-Don, Russia
K. Bogomolova
Rostov State Medical University
Email: bowsaw@mail.ru
4th-year student of the Faculty of Pediatrics Rostov-on-Don, Russia
I. Adamokova
Rostov State Medical University
Email: irina_adamokova@mail.ru
5th-year student of the Faculty of Pediatrics Rostov-on-Don, Russia
参考
- Koppe L., Fouque D., Kalantar-Zadeh K. Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers. J. Cachexia Sarcopenia Muscle. 2019;10(3):479-484. doi: 10.1002/jcsm.12421.
- Ветчинникова О.Н., Пичугина И.С. Белково-энергетическая недостаточность у пациентов с хронической болезнью почек на диализной терапии. Учебное пособие. М., 2015. 55 с.
- Смирнов А.В., Голубев Р.В., Коростелева Н.Ю., Румянцев А.Ш. Снижение физической работоспособности у больных, получающих заместительную почечную терапию: фокус на саркопению. Нефрология. 2017;21(4):9-29
- Mak R.H., Ikizler A.T., Kovesdy C.P., et al. Wasting in chronic kidney disease. J. Cachexia Sarcopenia Muscle. 2011;2(1):9-25.
- Schardong J., Marcolino M.Z, Plentz R.M. Muscle Atrophy in Chronic Kidney Disease. Adv. Exp. Med. Biol. 2018. In the book Atrophy of muscles. P. 393-412. Doi: 10.1007 / 978-981-13-1435-3_18.
- Kuzyarova A.S., Gasanov M.ZZ., Batyushin M.M., et al. The role of myostatin and protein kinase-в in the development of protein-energy wasting in patients with end-stage renal disease on hemodialysis. Georgian Med. News. 2019;4(289):47-50.
- Гасанов М.З. Молекулярные аспекты патогенеза саркопении у пациентов с хронической болезнью почек: интегративная роль mTOR. Нефрология. 2018;22(5):9-16.
- Sharma M., McFarlane C., Kambadur R., et al. Myostatin: Expanding horizons. IUBMB Life. 2015;67(8):589-600.
- Thomas S., Mitch W. Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin. Clin. Exp. Nephrol. 2013;17(2):174-82.
- Der-Sheng Han 1, Yung-Ming Chen, Sen-Yung Lin., et al. Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis. Clin. Endocrinol. (Otf). 2011; 75(6):857-63. Doi: 10.1111/j. 1365-2265.2011.04120.x.
- Wang X.H., Mitch W.E. Mechanisms of muscle wasting in chronic kidney disease. Nat. Rev. Nephrol. 2014;10(9):504-16. Doi.org/10.1038/nrneph.2014.112.
- Delanaye P., Bataille S., Quinonez K., et al. Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis. J. Ren. Nutr. 2019;29(6):511-20. Doi: 10.1053/j. jrn.2018.11.010.
- Яковенко А.А., Лаврищева Ю.В., Румянцев А.Ш. Новые возможности скрининга белково-энергетической недостаточности у пациентов, получающих лечение программным гемодиализом. Нефрология и диализ. 2019;21(2):243- 49.